PINL:GRPOF - Post by User
Comment by
equity4481on May 14, 2021 1:47pm
383 Views
Post# 33204388
RE:RE:Enrollment
RE:RE:EnrollmentI reached out to Media at TBP and Natalie advises the following:
Thank you for contacting Tetra. I trust this email finds you well.
I confirm, as stated in the Press Release of May 6, that the REBORN1 trial has started.
A separate Press Release, which was launched on May 11 regarding Tetra’s other clinical trial (PLENITUDE), announced the acceleration of the enrolment activities. The vaccination campaign has reduced the impact of the pandemic on hospitals which allows us to now accelerate enrolment. This trial began in September 2020 and is ongoing. Link below for your awareness.
https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2021/Tetra-Bio-Pharma-Accelerates-PLENITUDEC-Clinical-Trial-to-Evaluate-the-Effect-of-Cannabis-for-Use-in-Managing-Uncontrolled-Cancer-Pain/default.aspx
Kindest regards,
Natalie